Close

Catabasis Pharma (CATB): Preview of Edasalonexent Proof-Of-Concept Study - Wedbush

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to Catabasis Pharma (CATB): Preview of Edasalonexent Proof-Of-Concept Study - Wedbush
(NASDAQ: CATB) Delayed: 8.54 --0 (-0%)
Previous Close $8.54    52 Week High $10.83 
Open $0.03    52 Week Low $3.22 
Day High $8.54    P/E N/A 
Day Low $8.54    EPS $0.00 
Volume 51,250